![Mark Bach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bach
No open positions remaining
Net worth: 56 644 $ as of 31/05/2026
Profile
Dr. Mark A. Bach, MD, is a Senior Vice President-Clinical Development at Ascendis Pharma A/S. Dr. Bach was previously employed as a Chief Executive Officer by Accumulus Synergy, Inc, a Head-Asia Pacific Medical Sciences by Janssen Pharmaceuticals, Inc., a Vice President-Research & Development by Janssen Pharmaceutical KK, and a VP-Clinical Research Operations Worldwide by Merck & Co., Inc. He received his undergraduate degree from Carleton College, a doctorate degree from The University of Chicago and a doctorate degree from Baylor College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/03/2024 | 4,320 ( 0% ) | 56 644 $ | 31/05/2026 |
Former positions of Mark Bach
| Companies | Position | End |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 18/09/2024 |
Accumulus Synergy, Inc
 Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Chief Executive Officer | 01/10/2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/08/2019 |
Janssen Pharmaceutical KK
 Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/11/2012 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2010 |
Training of Mark Bach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Health Technology |
Carleton College
 Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Commercial Services |
- Stock Market
- Insiders
- Mark Bach
Choose MarketScreener 
